Report Summary
Eternity Insights has published a new study on Global Molecular Imaging Agents Market focusing on key segments as by Type (Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, Others), by Application (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Molecular Imaging Agents Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Molecular Imaging Agents Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Molecular Imaging Agents Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Molecular Imaging Agents Market Segmentation:
Molecular Imaging Agents Market, By Type
- Small Molecules
- Peptides
- Engineered Protein Fragments
- Aptamers
- Nanoparticles
- Others
Molecular Imaging Agents Market, By Application
- Oncology
- Cardiology
- Gastrointestinal Disorders
- Neurology Disorders
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Molecular Imaging Agents market in terms of demand generation. The Molecular Imaging Agents market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Molecular Imaging Agents market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Molecular Imaging Agents Market Taxonomy:
To learn more about this report
Global Molecular Imaging Agents Market Competitive Landscape
The global Molecular Imaging Agents market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- General Electric
- Bracco Diagnostic
- Eisai
- Guerbet
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Small Molecules, Peptides, Engineered Protein Fragments, Aptamers, Nanoparticles, Others |
| By Application Outlook |
Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
General Electric, Bracco Diagnostic, Eisai, Guerbet |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Molecular Imaging Agents Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Molecular Imaging Agents Market Size Growth Rate by Product
1.4.2 Small Molecules
1.4.3 Peptides
1.4.4 Engineered Protein Fragments
1.4.5 Aptamers
1.4.6 Nanoparticles
1.4.7 Others
1.5 Market by End User
1.5.1 Global Molecular Imaging Agents Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Gastrointestinal Disorders
1.5.5 Neurology Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Molecular Imaging Agents Market Size
2.1.1 Global Molecular Imaging Agents Revenue 2017-2027
2.1.2 Global Molecular Imaging Agents Sales 2017-2027
2.2 Molecular Imaging Agents Growth Rate by Regions
2.2.1 Global Molecular Imaging Agents Sales by Regions
2.2.2 Global Molecular Imaging Agents Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Molecular Imaging Agents Sales by Manufacturers
3.1.1 Molecular Imaging Agents Sales by Manufacturers
3.1.2 Molecular Imaging Agents Sales Market Share by Manufacturers
3.1.3 Global Molecular Imaging Agents Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Imaging Agents Revenue by Manufacturers
3.2.1 Molecular Imaging Agents Revenue by Manufacturers (2017-2020)
3.2.2 Molecular Imaging Agents Revenue Share by Manufacturers (2017-2020)
3.3 Molecular Imaging Agents Price by Manufacturers
3.4 Molecular Imaging Agents Manufacturing Base Distribution, Product Types
3.4.1 Molecular Imaging Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Molecular Imaging Agents Product Type
3.4.3 Date of International Manufacturers Enter into Molecular Imaging Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Molecular Imaging Agents Sales by Product
4.2 Global Molecular Imaging Agents Revenue by Product
4.3 Molecular Imaging Agents Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Molecular Imaging Agents Breakdown Data by End User
6 North America
6.1 North America Molecular Imaging Agents by Countries
6.1.1 North America Molecular Imaging Agents Sales by Countries
6.1.2 North America Molecular Imaging Agents Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Molecular Imaging Agents by Product
6.3 North America Molecular Imaging Agents by End User
7 Europe
7.1 Europe Molecular Imaging Agents by Countries
7.1.1 Europe Molecular Imaging Agents Sales by Countries
7.1.2 Europe Molecular Imaging Agents Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Molecular Imaging Agents by Product
7.3 Europe Molecular Imaging Agents by End User
8 Asia Pacific
8.1 Asia Pacific Molecular Imaging Agents by Countries
8.1.1 Asia Pacific Molecular Imaging Agents Sales by Countries
8.1.2 Asia Pacific Molecular Imaging Agents Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Molecular Imaging Agents by Product
8.3 Asia Pacific Molecular Imaging Agents by End User
9 Central & South America
9.1 Central & South America Molecular Imaging Agents by Countries
9.1.1 Central & South America Molecular Imaging Agents Sales by Countries
9.1.2 Central & South America Molecular Imaging Agents Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Molecular Imaging Agents by Product
9.3 Central & South America Molecular Imaging Agents by End User
10 Middle East and Africa
10.1 Middle East and Africa Molecular Imaging Agents by Countries
10.1.1 Middle East and Africa Molecular Imaging Agents Sales by Countries
10.1.2 Middle East and Africa Molecular Imaging Agents Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Molecular Imaging Agents by Product
10.3 Middle East and Africa Molecular Imaging Agents by End User
11 Company Profiles
11.1 General Electric
11.1.1 General Electric Company Details
11.1.2 Company Business Overview
11.1.3 General Electric Molecular Imaging Agents Sales, Revenue and Gross Margin (2017-2020)
11.1.4 General Electric Molecular Imaging Agents Products Offered
11.1.5 General Electric Recent Development
11.2 Bracco Diagnostic
11.2.1 Bracco Diagnostic Company Details
11.2.2 Company Business Overview
11.2.3 Bracco Diagnostic Molecular Imaging Agents Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Bracco Diagnostic Molecular Imaging Agents Products Offered
11.2.5 Bracco Diagnostic Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Company Business Overview
11.3.3 Eisai Molecular Imaging Agents Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Eisai Molecular Imaging Agents Products Offered
11.3.5 Eisai Recent Development
11.4 Guerbet
11.4.1 Guerbet Company Details
11.4.2 Company Business Overview
11.4.3 Guerbet Molecular Imaging Agents Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Guerbet Molecular Imaging Agents Products Offered
11.4.5 Guerbet Recent Development
12 Future Forecast
12.1 Molecular Imaging Agents Market Forecast by Regions
12.1.1 Global Molecular Imaging Agents Sales Forecast by Regions 2021-2027
12.1.2 Global Molecular Imaging Agents Revenue Forecast by Regions 2021-2027
12.2 Molecular Imaging Agents Market Forecast by Product
12.2.1 Global Molecular Imaging Agents Sales Forecast by Product 2021-2027
12.2.2 Global Molecular Imaging Agents Revenue Forecast by Product 2021-2027
12.3 Molecular Imaging Agents Market Forecast by End User
12.4 North America Molecular Imaging Agents Forecast
12.5 Europe Molecular Imaging Agents Forecast
12.6 Asia Pacific Molecular Imaging Agents Forecast
12.7 Central & South America Molecular Imaging Agents Forecast
12.8 Middle East and Africa Molecular Imaging Agents Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Molecular Imaging Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
